|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Paclitaxel. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (490)
Cases resulting in a serious event (482)
Cases resulting in death (113)
Cases resulting in life threatening events (61)
Cases resulting in hospitalization (333)
Cases resulting in disability (19)
Cases resulting in other serious reactions (135)
Below is a sample of reports where side effects / adverse reactions may be related to Paclitaxel. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Paclitaxel
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient: female, weighing 70.8 kg (155.8 pounds)
Adverse reactions / side effects: Gastroenteritis Proteus, Skin Graft, Pseudomonas Infection, Hyperplasia, Staphylococcal Infection, Skin Odour Abnormal, Skin Infection, Vasculitis, Culture Wound Positive, Infected Skin Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Sutent
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2006-03-30
End date: 2007-10-23
Paclitaxel
Indication: Breast Cancer Metastatic
Start date: 2006-03-30
End date: 2006-09-07
Other drugs received by patient: Loperamide HCL; Epoetin Alfa; Neupogen; Ultram; Esomeprazole Magnesium; Fexofenadine; Furosemide; Potassium Chloride; Magnesium Sulfate
Adverse event in female receiving Paclitaxel
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient: female, weighing 56.2 kg (123.6 pounds)
Adverse reactions / side effects: Cellulitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Sutent
Administration route: Oral
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Other drugs received by patient: Procrit; Procrit; Senokot; Prilosec; Motrin; Lyrica
Adverse event in 69 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30
Patient: 69 year old female
Adverse reactions / side effects: Colitis Ischaemic, Drug Toxicity
Adverse event resulted in: hospitalization
Suspect drug(s):
Carboplatin
Indication: non-Small Cell Lung Cancer
Paclitaxel
Indication: non-Small Cell Lung Cancer
Adverse event in 63 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from Portugal on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Drug Interaction, Toxic Skin Eruption
Adverse event resulted in: disablity
Suspect drug(s):
Paclitaxel
Dosage: 270 mg, 1 in 3 wk), intravenous
Indication: Ovarian Epithelial Cancer
Start date: 2007-04-26
End date: 2007-07-24
Fluconazole
Dosage: oral
Administration route: Oral
Indication: Mucosal Inflammation
Start date: 2007-04-26
Other drugs received by patient: Carboplatin; Dicyclomine HCL; Metoclopramide; Doxylamine; Pyridoxine; Dosulepin
Adverse event in 64 year old male receiving Paclitaxel
Reported by a physician from Japan on 2007-10-30
Patient: 64 year old male
Adverse reactions / side effects: Back Pain, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Gw572016
Administration route: Oral
Indication: Gastric Cancer
Paclitaxel
Indication: Gastric Cancer
Adverse event in female receiving Paclitaxel
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: female, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Dyspnoea, Oedema Peripheral, Hypoxia
Adverse event resulted in: hospitalization
Suspect drug(s):
Sutent
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-10-18
End date: 2006-11-14
Sutent
Administration route: Oral
Start date: 2006-11-15
End date: 2006-12-08
Paclitaxel
Indication: Breast Cancer
Start date: 2006-10-17
End date: 2006-11-27
Other drugs received by patient: Vitamin CAP; Selenium; Vitamin A; Capsaicin; Ginkgo Biloba
Adverse event in female receiving Paclitaxel
Reported by a pharmacist from Germany on 2007-10-29
Patient: female
Adverse reactions / side effects: Dysgeusia, Neurotoxicity, Malaise, Nail Disorder, Abdominal Pain Upper
Suspect drug(s):
Gabapentin
Dosage: text:0.5 tablet
Administration route: Oral
Indication: Neurotoxicity
Carboplatin
Dosage: daily dose:500mg
Indication: Chemotherapy
Paclitaxel
Dosage: daily dose:294mg
Indication: Fallopian Tube Cancer
Start date: 2007-06-20
End date: 2007-10-04
Ranitidine
Indication: Prophylactic Chemotherapy
Start date: 2007-06-20
End date: 2007-10-04
Adverse event in 46 year old female receiving Paclitaxel
Reported by a individual with unspecified qualification from Finland on 2007-10-26
Patient: 46 year old female
Adverse reactions / side effects: Back Pain, Vomiting, Visual Disturbance, Rash Erythematous, Unevaluable Event
Adverse event resulted in: hospitalization
Suspect drug(s):
Paclitaxel
Other drugs received by patient: Cetirizin; Oradexon TAB; Ranimex
Adverse event in 59 year old female receiving Paclitaxel
Reported by a individual with unspecified qualification from Finland on 2007-10-26
Patient: 59 year old female
Adverse reactions / side effects: Back Pain, Burning Sensation, Dyspnoea
Adverse event resulted in: hospitalization
Suspect drug(s):
Paclitaxel
Adverse event in 70 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 70 year old female, weighing 71.0 kg (156.2 pounds)
Adverse reactions / side effects: Pneumonia, Atrial Fibrillation, Febrile Neutropenia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Paclitaxel
Dosage: 355 mg 1 in 3 week, iv, on 18-jun-2007 310 mg 1 in 3 week, iv, on 09-jul-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-07-30
End date: 2007-07-30
Carboplatin
Dosage: 645 mg 1 in 3 week, iv, on 18-jun-2007 480 mg 1 in 3 week, iv, on 09-jul-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-07-30
End date: 2007-07-30
Other drugs received by patient: Neulasta; Levaquin
Adverse event in female receiving Paclitaxel
Reported by a pharmacist from Germany on 2007-10-26
Patient: female
Adverse reactions / side effects: Neurotoxicity, Dysgeusia, Malaise, Nail Disorder, Abdominal Pain Upper
Suspect drug(s):
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-06-20
End date: 2007-06-20
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-07-11
End date: 2007-07-11
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-08-01
End date: 2007-08-01
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-08-22
End date: 2007-08-22
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-09-12
End date: 2007-09-12
Ranitidine
Dosage: see image
Indication: Prophylaxis
Start date: 2007-10-04
End date: 2007-10-04
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-06-20
End date: 2007-06-20
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-07-11
End date: 2007-07-11
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-08-01
End date: 2007-08-01
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-08-22
End date: 2007-08-22
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-09-12
End date: 2007-09-12
Carboplatin
Dosage: see image
Indication: Chemotherapy
Start date: 2007-10-04
End date: 2007-10-04
Gabapentin
Dosage: oral
Administration route: Oral
Indication: Neurotoxicity
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-06-20
End date: 2007-06-20
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-07-11
End date: 2007-07-11
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-08-01
End date: 2007-08-01
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-08-22
End date: 2007-08-22
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-09-12
End date: 2007-09-12
Paclitaxel
Dosage: see image
Indication: Fallopian Tube Cancer
Start date: 2007-10-04
End date: 2007-10-04
Other drugs received by patient: Sodium Chloride (Sodium Chloride) Solution FOR Infusion, 0.9%; Tropisetron (Tropisetron); Metoclopramide (Metoclopramide)
Adverse event in 60 year old female receiving Paclitaxel
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 60 year old female, weighing 74.0 kg (162.8 pounds)
Adverse reactions / side effects: Neuropathy, White Blood Cell Count Decreased, Stomatitis, Blood Albumin Decreased, Febrile Neutropenia, Rash, Haemoglobin Decreased, Fatigue, Dehydration, Anorexia, Protein Total Increased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-11
End date: 2007-10-11
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-11
End date: 2007-10-11
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-11
End date: 2007-10-11
Bevacizumab
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-11
End date: 2007-10-11
Adverse event in female receiving Paclitaxel
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: female
Adverse reactions / side effects: Abdominal Pain Upper
Adverse event resulted in: hospitalization
Suspect drug(s):
Carboplatin
Indication: Ovarian Cancer Metastatic
Start date: 2007-08-21
Paclitaxel
Indication: Ovarian Cancer Metastatic
Start date: 2007-08-21
Dasatinib
Administration route: Oral
Indication: Ovarian Cancer Metastatic
Start date: 2007-08-22
Adverse event in 67 year old male receiving Paclitaxel
Reported by a physician from United States on 2007-10-23
Patient: 67 year old male, weighing 73.0 kg (160.6 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Neutrophil Count Increased, Pneumonia, Blood Phosphorus Increased, Effusion, International Normalised Ratio Increased, Platelet Count Increased, Condition Aggravated, Prothrombin Time Prolonged, Blood Urea Nitrogen / Creatinine Ratio Increased, Respiratory Distress, Blood Calcium Decreased, Haemoglobin Decreased, Haematocrit Decreased, Bilirubin Conjugated Increased, Lymphocyte Count Decreased
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg unit dose: 200 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-08
End date: 2007-09-17
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-07
End date: 2007-08-07
Carboplatin
Start date: 2007-08-28
End date: 2007-08-28
Paclitaxel
Dosage: unit dose: 225 mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-07
End date: 2007-08-07
Paclitaxel
Dosage: unit dose: 225 mg/m2
Start date: 2007-08-28
End date: 2007-08-28
Other drugs received by patient: Nasal Oxygen; Nasal Oxygen; Nasal Oxygen; Zoloft; Lipitor; Lipitor; Zantac; Multi-Vitamin; Aspirin; Advair Diskus 100 / 50; Ativan; Viagra; Albuterol; Imodium; Lomotil; Decadron; Decadron; Decadron; Aspirin; Zofran; Zofran; Pepcid; Pepcid; Benadryl; Benadryl
Adverse event in 71 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: 71 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Cardiomyopathy, Pneumonitis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Paclitaxel
Dosage: 90mg/m2, frequency:weekly, interval:q3weeks,1wk rest, iv
Indication: Breast Cancer
Start date: 2007-08-07
Bevacizumab
Dosage: 10 mg/kg,frequency:q2weeks;interval:q2weeks, iv
Indication: Breast Cancer
Start date: 2007-08-07
Other drugs received by patient: Folic Acid; Toprol-XL; Plavix; Imdur; Cimetidine; Oxycodone HCL; Caduet; Benadryl; Codeine + Guaifenesin; Megace
Adverse event in male receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Urinary Tract Obstruction, Abdominal Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Cetuximab
Indication: Transitional Cell Carcinoma
Paclitaxel
Adverse event in female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: female, weighing 71.3 kg (156.9 pounds)
Adverse reactions / side effects: Abdominal Pain Upper
Adverse event resulted in: hospitalization
Suspect drug(s):
Carboplatin
Dosage: auc 5 q 3 weeks iv (duration: until disease progression)
Indication: Ovarian Cancer
Paclitaxel
Dosage: 150 mg/m2 q 3 weeks iv (duration: until disease progression)
Indication: Ovarian Cancer
Other drugs received by patient: Dasatinib; Zofran
Adverse event in 48 year old male receiving Paclitaxel
Reported by a physician from Singapore on 2007-10-22
Patient: 48 year old male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Drug Dose Omission, Vomiting, Dyspnoea, Rash, Headache, Thirst, Death, Feeling Hot, Chest Pain
Adverse event resulted in: death
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-03
End date: 2007-10-13
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-02
End date: 2007-10-02
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-02
End date: 2007-10-02
Other drugs received by patient: Morphine; Celebrex; Senna; Lactulose
Adverse event in female receiving Paclitaxel
Reported by a individual with unspecified qualification from United States on 2007-10-22
Patient: female, weighing 53.3 kg (117.3 pounds)
Adverse reactions / side effects: Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Sutent
Administration route: Oral
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Other drugs received by patient: Epoetin Alfa; Acetaminophen; Alprazolam; Neupogen
Adverse event in 67 year old male receiving Paclitaxel
Reported by a physician from United States on 2007-10-19
Patient: 67 year old male, weighing 73.0 kg (160.6 pounds)
Adverse reactions / side effects: Pneumonia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg unit dose: 200 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-08
End date: 2007-09-17
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-07
End date: 2007-08-07
Carboplatin
Start date: 2007-08-28
End date: 2007-08-28
Paclitaxel
Dosage: unit dose: 225 mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-07
End date: 2007-08-07
Paclitaxel
Dosage: unit dose: 225 mg/m2
Start date: 2007-08-28
End date: 2007-08-28
Other drugs received by patient: Nasal Oxygen; Nasal Oxygen; Nasal Oxygen; Zoloft; Lipitor; Lipitor; Zantac; Multi-Vitamin; Aspirin; Advair Diskus 100 / 50; Ativan; Viagra; Albuterol; Imodium; Lomotil; Decadron; Decadron; Decadron; Aspirin; Zofran; Zofran; Pepcid; Pepcid; Benadryl; Benadryl
Adverse event in 54 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: 54 year old female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Hot Flush, Arthralgia, Diarrhoea, Rectal Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Paclitaxel
Indication: Breast Cancer
Start date: 2007-09-26
End date: 2007-09-26
Cyclophosphamide
Indication: Breast Cancer
Start date: 2007-09-05
End date: 2007-09-05
Gemcitabine HCL
Indication: Breast Cancer
Start date: 2007-09-26
End date: 2007-09-26
Epirubicin
Indication: Breast Cancer
Start date: 2007-09-05
End date: 2007-09-05
Other drugs received by patient: Paracetamol; Atenolol; Zopiclone; Sodium Chloride
Adverse event in 56 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-18
Patient: 56 year old female
Adverse reactions / side effects: Cutaneous Lupus Erythematosus
Suspect drug(s):
Paclitaxel
Adverse event in 48 year old male receiving Paclitaxel
Reported by a physician from Singapore on 2007-10-18
Patient: 48 year old male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Death, Dyspnoea
Adverse event resulted in: death
Suspect drug(s):
Sorafenib
Dosage: total daily dose: 800 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-03
End date: 2007-10-13
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-02
End date: 2007-10-02
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2007-10-02
End date: 2007-10-02
Other drugs received by patient: Morphine; Celebrex; Senna; Lactulose
Adverse event in 46 year old female receiving Paclitaxel
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-17
Patient: 46 year old female
Adverse reactions / side effects: Cutaneous Lupus Erythematosus
Suspect drug(s):
Paclitaxel
Adverse event in female receiving Paclitaxel
Reported by a consumer/non-health professional from United Kingdom on 2007-10-17
Patient: female, weighing 41.9 kg (92.2 pounds)
Adverse reactions / side effects: Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 629 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-01
Paclitaxel
Dosage: 272 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-01
Carboplatin
Dosage: 539 mg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-08-01
Other drugs received by patient: Oxycodone HCL; Fentanyl; Metoclopramide; Triamcinolone; Prochlorperazine; Loxoprofen Sodium; Sennosides; Chinese Medicine; Nortriptyline HCL; Magnesium Oxide; Teprenone; Flurbiprofen
|
